CLINICAL DEVELOPMENT OF CRISPR-CAS3 PHAGE COCKTAIL FOR THE TREATMENT OF RECURRENT URINARY TRACT INFECTIONS CAUSED BY ESCHERICHIA COLI INCLUDING ANTIMICROBIAL AND MULTI-DRUG RESISTANT STRAINS
$48,946,433
| Recipient | LOCUS BIOSCIENCES INC UEI CJKVLKZGX6F3 |
|---|---|
| Award ID | 75A50120C00169 |
| Award amount | $48,946,433 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AN13 |
| Start date | Sep 28, 2020 |
| End date | Sep 30, 2025 |
| Place of performance | MORRISVILLE, NC |
| Record updated | Jun 12, 2024 |
View the official award record
More awards won by LOCUS BIOSCIENCES INC
ADVANCE A NOVEL THERAPEUTIC TO A FIRST-IN-HUMAN CLINICAL STUDY
Department of Health and Human Services · $3,318,955 · Sep 24, 2025
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids